Cerus Corporation (CERS) was a big mover last session, as its shares rose nearly 7% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company, as the stock is now down almost 12% in the past one-month timeframe.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cerus currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Baxter International Inc. (BAX), PositiveID Corporation (PSID) and Covidien plc (COV). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CERUS CP (CERS): Free Stock Analysis Report
BAXTER INTL INC (BAX): Free Stock Analysis Report
POSITIVEID CORPORATI (PSID): Free Stock Analysis Report
COVIDIEN PLC NEW (COV): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading